POTEJ
gene geneOn this page
Also known as POTE2beta
Summary
POTEJ (POTE ankyrin domain family member J, HGNC:37094) is a protein-coding gene on chromosome 2q21.1, encoding POTE ankyrin domain family member J (P0CG39).
Predicted to enable protein kinase binding activity. Predicted to be a structural constituent of postsynaptic actin cytoskeleton. Predicted to be involved in axonogenesis and cell motility. Located in extracellular exosome.
Source: NCBI Gene 653781 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 12 total
- MANE Select transcript:
NM_001277083
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37094 |
| Approved symbol | POTEJ |
| Name | POTE ankyrin domain family member J |
| Location | 2q21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | POTE2beta |
| Ensembl gene | ENSG00000222038 |
| Ensembl biotype | protein_coding |
| Entrez | 653781 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000409602
RefSeq mRNA: 1 — MANE Select: NM_001277083
NM_001277083
CCDS: CCDS59432
Canonical transcript exons
ENST00000409602 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001723108 | 130611440 | 130611942 |
| ENSE00002434805 | 130617065 | 130617238 |
| ENSE00002442943 | 130616790 | 130616904 |
| ENSE00002453749 | 130629949 | 130630019 |
| ENSE00002457441 | 130645737 | 130645781 |
| ENSE00002461380 | 130654921 | 130655041 |
| ENSE00002468159 | 130631409 | 130631453 |
| ENSE00002470102 | 130621466 | 130621603 |
| ENSE00002472997 | 130620045 | 130620151 |
| ENSE00002496629 | 130638619 | 130638689 |
| ENSE00002499512 | 130624064 | 130624134 |
| ENSE00002501018 | 130632490 | 130632656 |
| ENSE00002508231 | 130646129 | 130646310 |
| ENSE00002509853 | 130643983 | 130644053 |
| ENSE00002513344 | 130656549 | 130658037 |
Expression profiles
Bgee: expression breadth broad, 18 present calls, max score 81.19.
Top tissues by expression
119 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.19 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.57 | silver quality |
| cortical plate | UBERON:0005343 | 45.27 | gold quality |
| ganglionic eminence | UBERON:0004023 | 44.07 | gold quality |
| prostate gland | UBERON:0002367 | 38.53 | gold quality |
| bone marrow cell | CL:0002092 | 38.21 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| right atrium auricular region | UBERON:0006631 | 36.69 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 36.10 | silver quality |
| sural nerve | UBERON:0015488 | 35.27 | gold quality |
| right uterine tube | UBERON:0001302 | 34.93 | gold quality |
| testis | UBERON:0000473 | 34.52 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 33.96 | silver quality |
| bone marrow | UBERON:0002371 | 33.83 | gold quality |
| tonsil | UBERON:0002372 | 33.80 | gold quality |
| fundus of stomach | UBERON:0001160 | 32.91 | gold quality |
| duodenum | UBERON:0002114 | 32.48 | gold quality |
| endometrium | UBERON:0001295 | 32.09 | gold quality |
| stomach | UBERON:0000945 | 31.74 | silver quality |
| urinary bladder | UBERON:0001255 | 31.71 | gold quality |
| left testis | UBERON:0004533 | 31.59 | silver quality |
| blood | UBERON:0000178 | 31.58 | gold quality |
| mucosa of stomach | UBERON:0001199 | 31.56 | gold quality |
| lymph node | UBERON:0000029 | 30.93 | gold quality |
| right testis | UBERON:0004534 | 30.89 | gold quality |
| prefrontal cortex | UBERON:0000451 | 30.70 | gold quality |
| body of stomach | UBERON:0001161 | 30.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| liver | UBERON:0002107 | 29.79 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 29.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
19 targeting POTEJ, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-4251 | 99.40 | 69.19 | 3363 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-6770-5P | 98.97 | 66.76 | 1853 |
| HSA-MIR-412-3P | 98.86 | 66.89 | 712 |
| HSA-MIR-6754-3P | 98.84 | 66.60 | 889 |
| HSA-MIR-4303 | 98.01 | 68.13 | 2304 |
| HSA-MIR-192-3P | 97.52 | 67.66 | 1001 |
| HSA-MIR-937-5P | 97.43 | 68.39 | 667 |
| HSA-MIR-6872-3P | 97.08 | 66.99 | 750 |
| HSA-MIR-4664-3P | 88.57 | 63.79 | 80 |
Cross-species orthologs
0 orthologs
Paralogs (16): BCL3 (ENSG00000069399), NFKBIE (ENSG00000146232), POTED (ENSG00000166351), POTEC (ENSG00000183206), POTEG (ENSG00000187537), POTEE (ENSG00000188219), POTEA (ENSG00000188877), POTEF (ENSG00000196604), POTEI (ENSG00000196834), POTEH (ENSG00000198062), POTEM (ENSG00000222036), POTEB2 (ENSG00000230031), POTEB (ENSG00000233917), (ENSG00000276760), (ENSG00000277630), POTEB3 (ENSG00000278522)
Protein
Protein identifiers
POTE ankyrin domain family member J — P0CG39 (reviewed: P0CG39)
All UniProt accessions (1): P0CG39
UniProt curated annotations — full annotation on UniProt →
Similarity. In the N-terminal section; belongs to the POTE family. In the C-terminal section; belongs to the actin family.
RefSeq proteins (1): NP_001264012* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR004000 | Actin | Family |
| IPR004001 | Actin_CS | Conserved_site |
| IPR020902 | Actin/actin-like_CS | Conserved_site |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR039497 | CC144C-like_CC_dom | Domain |
| IPR043129 | ATPase_NBD | Homologous_superfamily |
Pfam: PF00022, PF12796, PF14915
UniProt features (15 total): repeat 5, compositionally biased region 5, region of interest 3, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG39-F1 | 72.20 | 0.46 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GOBP_NEUROGENESIS, GOBP_CELL_JUNCTION_ORGANIZATION, GOCC_NEURON_PROJECTION, GOBP_CELL_PROJECTION_ORGANIZATION, GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX, GOCC_TRANSFERASE_COMPLEX, GOCC_SYNAPSE, GOCC_AXON, GOMF_KINASE_BINDING, GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON, GOMF_STRUCTURAL_MOLECULE_ACTIVITY, GOBP_SYNAPSE_ORGANIZATION, GOBP_AXON_DEVELOPMENT, GOBP_POSTSYNAPSE_ORGANIZATION, GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION
GO Biological Process (3): axonogenesis (GO:0007409), cell motility (GO:0048870), postsynaptic actin cytoskeleton organization (GO:0098974)
GO Molecular Function (3): protein kinase binding (GO:0019901), structural constituent of postsynaptic actin cytoskeleton (GO:0098973), protein binding (GO:0005515)
GO Cellular Component (9): obsolete extracellular space (GO:0005615), cytoplasm (GO:0005737), actin filament (GO:0005884), actin cytoskeleton (GO:0015629), membrane (GO:0016020), axon (GO:0030424), NuA4 histone acetyltransferase complex (GO:0035267), synapse (GO:0045202), extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cell morphogenesis involved in neuron differentiation | 1 |
| neuron projection morphogenesis | 1 |
| axon development | 1 |
| cellular process | 1 |
| actin cytoskeleton organization | 1 |
| postsynaptic cytoskeleton organization | 1 |
| kinase binding | 1 |
| structural constituent of cytoskeleton | 1 |
| postsynaptic actin cytoskeleton | 1 |
| postsynaptic actin cytoskeleton organization | 1 |
| structural constituent of postsynapse | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| actin cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
| cytoskeleton | 1 |
| neuron projection | 1 |
| H4/H2A histone acetyltransferase complex | 1 |
| cell junction | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
578 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| POTEJ | TRIM49C | P0CI26 | 470 |
| POTEJ | NMT1 | P30419 | 456 |
| POTEJ | AGAP4 | Q96P64 | 400 |
| POTEJ | CCDC183 | Q5T5S1 | 394 |
| POTEJ | PPP1R37 | O75864 | 372 |
| POTEJ | ZNG1C | Q5JTY5 | 371 |
| POTEJ | A0A087WTP8 | A0A087WTP8 | 353 |
| POTEJ | TRIM49 | P0CI25 | 348 |
| POTEJ | ZNF418 | Q8TF45 | 348 |
| POTEJ | AMER3 | Q8N944 | 322 |
| POTEJ | GPR148 | Q8TDV2 | 307 |
| POTEJ | ABRACL | Q9P1F3 | 297 |
| POTEJ | ARGLU1 | Q9NWB6 | 290 |
| POTEJ | CDH24 | Q86UP0 | 271 |
| POTEJ | VSIG2 | Q96IQ7 | 270 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| BCL7A | ARID1A | psi-mi:“MI:0914”(association) | 0.640 |
| INSR | PIK3R2 | psi-mi:“MI:2364”(proximity) | 0.570 |
| CFTR | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.480 |
| CFTR | CNOT1 | psi-mi:“MI:0914”(association) | 0.480 |
| CAT | NUDT19 | psi-mi:“MI:0914”(association) | 0.420 |
| BCL7A | DPF1 | psi-mi:“MI:0914”(association) | 0.350 |
| RIN3 | psi-mi:“MI:0914”(association) | 0.350 | |
| CTBP1 | TAF15 | psi-mi:“MI:0914”(association) | 0.350 |
| CFTR | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| HCN1 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| CAP2 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| PFN3 | POTEJ | psi-mi:“MI:0914”(association) | 0.350 |
| VP24 | POTEF | psi-mi:“MI:0914”(association) | 0.350 |
| NDN | HDLBP | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (77): POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS), POTEJ (Affinity Capture-MS)
ESM2 similar proteins: A0A072TK64, A0A072ULZ1, A0A6P8HC43, A2PYL6, A2PYL7, A2PYL8, A2XE45, A2XEA0, A2Y6J9, A5A3E0, B5DUH6, E9Q0N2, F4HWL4, F4JCB2, O04309, O08528, O24521, O95744, P0CG38, P0CG39, P25071, P27881, P28316, P29127, P35753, P37842, P52789, Q1W674, Q29428, Q6S8J3, Q70SU7, Q70SU8, Q75II4, Q84JE8, Q8L727, Q8LRK8, Q8RXK2, Q8VC49, Q90WJ7, Q93Y92
Diamond homologs: A0A0A6YYL3, A0JP26, A0PJZ0, A2A2Z9, A2RUR9, A5A3E0, A6NC57, A6NI47, A7E2S9, B2RU33, H3BUK9, P0CG38, P0CG39, Q3MJ40, Q4R3S3, Q4UJ75, Q5CZ79, Q5JPF3, Q5SQ80, Q5TYW2, Q5VUR7, Q6NSI1, Q6S545, Q6S5H5, Q6S8J3, Q6S8J7, Q811D2, Q86YR6, Q8IYA2, Q92527, Q9BXX2, Q9BXX3, Q9D504, Q9H560, Q9UPS8, Q8IVF6, A6QL64, Q8N2N9, Q8NF67, Q96IX9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
12 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 9 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1720 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:130611940:G:GT | donor_gain | 1.0000 |
| 2:130611940:GAG:G | donor_gain | 1.0000 |
| 2:130617048:T:TA | acceptor_gain | 1.0000 |
| 2:130617054:A:AG | acceptor_gain | 1.0000 |
| 2:130617055:A:G | acceptor_gain | 1.0000 |
| 2:130617059:T:A | acceptor_gain | 1.0000 |
| 2:130617235:CAAGG:C | donor_loss | 1.0000 |
| 2:130617236:AAGG:A | donor_loss | 1.0000 |
| 2:130617238:GGTA:G | donor_loss | 1.0000 |
| 2:130617239:G:GA | donor_loss | 1.0000 |
| 2:130617240:T:G | donor_loss | 1.0000 |
| 2:130620044:GC:G | acceptor_gain | 1.0000 |
| 2:130620044:GCAT:G | acceptor_gain | 1.0000 |
| 2:130620149:A:T | donor_gain | 1.0000 |
| 2:130621464:A:AG | acceptor_gain | 1.0000 |
| 2:130621465:G:GA | acceptor_gain | 1.0000 |
| 2:130621465:GAACT:G | acceptor_gain | 1.0000 |
| 2:130621602:GT:G | donor_gain | 1.0000 |
| 2:130621604:G:GG | donor_gain | 1.0000 |
| 2:130624059:CATA:C | acceptor_loss | 1.0000 |
| 2:130624061:TAGA:T | acceptor_loss | 1.0000 |
| 2:130624062:A:AG | acceptor_gain | 1.0000 |
| 2:130624062:A:C | acceptor_loss | 1.0000 |
| 2:130624063:G:GG | acceptor_gain | 1.0000 |
| 2:130624063:GA:G | acceptor_gain | 1.0000 |
| 2:130632483:A:AG | acceptor_gain | 1.0000 |
| 2:130632485:TCAAG:T | acceptor_loss | 1.0000 |
| 2:130632487:AAG:A | acceptor_gain | 1.0000 |
| 2:130632488:A:G | acceptor_gain | 1.0000 |
| 2:130632489:G:GG | acceptor_gain | 1.0000 |
AlphaMissense
6971 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:130616804:T:C | L142P | 0.991 |
| 2:130621519:T:C | L287P | 0.988 |
| 2:130657119:T:C | F787L | 0.988 |
| 2:130657121:T:A | F787L | 0.988 |
| 2:130657121:T:G | F787L | 0.988 |
| 2:130617102:T:C | L188S | 0.986 |
| 2:130617105:T:C | L189P | 0.986 |
| 2:130617201:T:C | L221P | 0.986 |
| 2:130617065:G:C | A176P | 0.985 |
| 2:130617134:G:C | D199H | 0.985 |
| 2:130657128:T:C | F790L | 0.984 |
| 2:130657130:C:A | F790L | 0.984 |
| 2:130657130:C:G | F790L | 0.984 |
| 2:130611861:C:A | A110D | 0.983 |
| 2:130620139:A:T | D265V | 0.983 |
| 2:130657767:T:A | W1003R | 0.983 |
| 2:130657767:T:C | W1003R | 0.983 |
| 2:130616876:A:T | D166V | 0.982 |
| 2:130611891:T:C | L120P | 0.981 |
| 2:130617134:G:T | D199Y | 0.981 |
| 2:130621582:C:A | A308D | 0.981 |
| 2:130617235:C:A | N232K | 0.980 |
| 2:130617235:C:G | N232K | 0.980 |
| 2:130620069:G:C | G242R | 0.980 |
| 2:130616843:T:C | L155P | 0.978 |
| 2:130617135:A:T | D199V | 0.978 |
| 2:130620067:T:C | L241P | 0.978 |
| 2:130621480:T:C | L274P | 0.978 |
| 2:130657803:T:C | F1015L | 0.978 |
| 2:130657805:C:A | F1015L | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000305412 (2:130654459 C>G), RS1000566233 (2:130658312 G>C), RS1000626227 (2:130655938 A>C), RS1000673038 (2:130637245 C>A,T), RS1000785402 (2:130636795 A>G), RS1001464202 (2:130634416 T>C), RS1001472236 (2:130656098 T>C), RS1001619467 (2:130656966 C>G,T), RS1001798341 (2:130656414 C>T), RS1001852285 (2:130639939 T>C), RS1001914249 (2:130637966 T>A), RS1002134743 (2:130610568 T>C), RS1002421987 (2:130612960 C>T), RS1003454894 (2:130613290 ATATATATACATATG>A,ATATATATACATATGTATATATACATATG), RS1003528216 (2:130644361 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| beauvericin | affects cotreatment, decreases expression | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| enniatins | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Oxygen | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.